We've Got Your Back.
Whether you're tracking dilution filings, biotech catalysts, or market signals — we're here to make sure every platform works as hard as you do.
Guerilla Finance operates a fleet of specialized financial intelligence platforms. Find the right contact for your platform below.
DilutionWatch
dilutionwatch.comSEC filing alerts, dilution risk scores, stock tracking, institutional 13F analysis, and the Pulse dashboard.
BiotechSign
biotechsign.comFDA catalyst tracking, PDUFA calendar, clinical trial monitoring, biotech screening, and pipeline intelligence.
Contract-Trader
contract-trader.comGovernment procurement intelligence. SAM.gov award flow, USASpending contract history, heatmap, and contractor risk flags mapped to public tickers.
General / Corporate
Account issues, billing, API marketplace, partnership inquiries, and anything that doesn't fit a specific platform.
How fast are dilution alerts delivered?
Our SEC EDGAR sentinel processes new filings continuously. From the moment a filing hits EDGAR to the moment your alert lands in your inbox — typically under 60 seconds. Basic and Premium subscribers receive real-time alerts. Free tier users receive a daily digest.
What does the Dilution Score actually measure?
The Dilution Score is a proprietary 5-component model that evaluates: filing severity and type classification, float erosion risk based on outstanding shares analysis, warrant and convertible securities detection via XBRL parsing, institutional holdings movement from 13F data, and historical dilution patterns for the company. Each component is data-driven — no subjective ratings, no guesswork.
How many tickers can I watch?
Free accounts include limited ticker lookups and a small watchlist. Basic ($19.95/mo) supports a 10-ticker watchlist with real-time SEC filing alerts. Premium ($39.95/mo) supports a 30-ticker watchlist with AI analysis and institutional tracking. All tiers include Pulse dashboard access.
What is the Pulse dashboard?
Pulse is our live market intelligence view — a real-time dilution risk radar across every public company in our system. It shows active dilution scores, recent filing activity, and risk trends at a glance. Think of it as your early warning system for the entire market.
What filing types does DilutionWatch track?
We monitor all SEC filing types relevant to dilution: S-3 shelf registrations, S-1 registration statements, prospectus supplements (424B), 8-K current reports with dilution indicators, warrant exercises, convertible note conversions, and more. Our classifier categorizes each filing by dilution relevance and severity.
Can I cancel my subscription anytime?
Yes. No contracts, no cancellation fees, no hidden terms. Cancel directly from your account settings and your access continues through the end of your billing period. We keep your business by earning it, not by trapping you.
Is my data secure?
All connections are encrypted via TLS. Authentication uses secure session tokens. API endpoints are rate-limited and access-controlled by subscription tier. Payment processing is handled by Stripe — we never see or store your card details. Our infrastructure runs in containerized isolation with authenticated email delivery (DKIM, SPF, DMARC verified).
How do I report a data issue?
Accuracy is everything to us. If you spot a discrepancy in a dilution score, filing classification, or any data point, reach out immediately via the contact form or email support@dilutionwatch.com. We investigate every report and we take them seriously.
What is a Catalyst Score?
The Catalyst Score is a composite metric that quantifies the significance and potential market impact of upcoming biotech events. It factors in trial phase, therapeutic area market size, historical approval rates for similar drugs, company fundamentals, and time-to-event proximity. Higher scores indicate catalysts more likely to generate significant price movement.
How often are PDUFA dates updated?
PDUFA dates are monitored in real time from SEC filings and FDA announcements. When the FDA issues a Complete Response Letter, approval, or date extension, our system captures and reflects the change within minutes. We cross-reference ClinicalTrials.gov, FDA.gov, and company 8-K filings continuously.
Can I track specific biotech companies?
Yes. BiotechSign includes a full watchlist feature that lets you follow specific companies and receive alerts when new catalysts are identified, trial status changes, or FDA actions occur. You can also filter your dashboard by watchlist to focus on the names that matter to you.
What therapeutic sectors are covered?
BiotechSign tracks catalysts across eight major therapeutic sectors: oncology, immunology, neurology, cardiovascular, rare diseases, infectious disease, metabolic disorders, and gene therapy/cell therapy. Coverage is expanding as new clinical data sources are integrated.
Does BiotechSign cover clinical trial results?
Yes. We track trial phase transitions, interim data readouts, primary endpoint results, and regulatory milestones. Our system parses press releases and SEC filings to surface trial outcome data as soon as it becomes publicly available.
Where does Contract-Trader's data come from?
Contract-Trader ingests award data from verified federal procurement databases covering active contract opportunities and historical awards. Data is normalized, deduplicated, and mapped to public company tickers via EDGAR subsidiary resolution.
How often is the contract data updated?
New contract opportunities and award records are ingested continuously. The heatmap aggregates update on a rolling basis, and ticker-level contract history includes over a year of backfill.
What tickers are covered?
Contract-Trader covers public companies with material federal procurement activity. Coverage spans defense contractors, IT services, healthcare, infrastructure, and professional services firms that hold or bid for federal contracts.
What is a contractor risk flag?
Risk flags surface anomalies including debarment or suspension history, unusually high modification rates on existing contracts, extreme award concentration in a single agency, and deviation from a company's historical contract award pace.
Paid subscribers are prioritized.
engines run 24/7. Scheduled
maintenance is announced via email.
best features started as user requests.
Email us anytime.